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Abstract 
Aminopeptidase N (EC 3A. 11.2) (APN) is an ectopeptidase expressed in lung at the apical surface of alveolar type II epithelial cells. 
Its expression is up-regulated uring fetal lung development. Recently several ectopeptidases have been recognized as possible regulators 
of growth and cell differentiation through their role in hydrolysis of autocrine and paracrine peptides that influence these processes. The 
studies reported here describe effects of factors known to promote lung development and differentiation of the alveolar epithelium on 
expression of aminopeptidase N during fetal lung development in organ culture. Fetal rat lung was placed in organ culture at the 15th 
gestational day and cultured for 6 days in the presence or absence of the synthetic glucocorticoid hormone dexamethasone or epidermal 
growth factor (EGF). Steady-state l vels of APN mRNA increased approximately 10-fold during the 6-day culture. During this time the 
lung alveolar epithelium developed to the point where immature alveolar type II cells were recognized by the presence of lamellar bodies. 
Dexamethasone or EGF increased the levels of APN mRNA in the fetal lung 2-to 3-fold over control cultures by the third day in culture 
and concurrently accelerated the morphological development of the alveolar epithelium. Differences in treated and control cultures 
diminished after 6 days in culture when the epithelium appeared more mature, suggesting that the immature pithelium was more 
responsive to the treatments. 
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1. Introduction 
Efforts to identify proteins that serve as markers of 
pulmonary alveolar epithefial cells led to the discovery that 
aminopeptidase N is an apical membrane marker for the 
type II alveolar epithelial cells in adult rat lung. In the fetal 
rat (gestation period, 22 days), the APN is expressed in the 
lung as early as the 14th gestational day, before differentia- 
tion of cells recognized as alveolar type II epithelial cells. 
At this early stage of lung development, the APN is 
present on the columnar glandular epithelial cells lining 
the respiratory ducts in the distal portion of the tracheo- 
bronchial tree. At 19 days gestation, the APN is present on 
the epithelial cells in the smallest ducts distal to the 
tracheobronchial tree. As more mature type II cells differ- 
entiate, the APN is restricted to the apical membrane of the 
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type II cells and is not detected on the alveolar type I 
epithelial cells [1]. 
The function of APN in the alveolar epithelium is not 
known. APN is a surface peptidase, classified as an ec- 
topeptidase because the enzyme active site is located at the 
extracellular surface. It is expressed by a number of extra- 
pulmonary cell types including epithelial cells of the renal 
proximal tubule, the brush border of the small intestine, 
and hematopoietic cells of myeloid lineage [2,3]. In some, 
but not all tissues where it is expressed, it is a component 
of a battery of ectopeptidases that may function together in 
the hydrolysis of peptides. One proposal is that APN may 
function with other peptidases in regulating growth and 
differentiation by their role in the proteolytic activation or 
inactivation of peptide growth factors that influence these 
processes [4]. This idea originated with the identification 
of several ectopeptidases among the cluster differentiation 
(CD) antigens of hematopoietic cells. Aminopeptidase N is 
identical to CD 13 which is expressed in a lineage-re- 
stricted pattern by subsets of normal and malignant 
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hematopoietic cells [3,5]. The CD antigens are markers of 
specific cell types within related lineages although they are 
found in widely different tissues [4]. The available data 
regarding the expression of APN in lung epithelial cells 
during fetal rat lung development [1], suggest hat it may 
serve as a lineage marker for the cells destined to become 
alveolar type II cells during differentiation of the pul- 
monary epithelium. Therefore, analysis of factors that con- 
tribute to APN expression may provide information about 
control of differentiation of epithelial cell lineages during 
development. 
The expression of APN in fetal rat lung is dramatically 
upregulated at about the time of birth, suggesting that its 
function may be related to an unrecognized ifferentiated 
function of type II cells or to the processes involved in cell 
differentiation [3,6]. To further establish the relationship 
between expression of APN and the development of the 
alveolar epithelium, we have investigated the effects of 
dexamethasone and epidermal growth factor, factors known 
to be important in lung development and expression of 
differentiated functions of alveolar type II cells, to deter- 
mine their effects on expression of APN during lung 
development in organ culture. 
2. Materials and methods 
2.1. Animals 
Timed-bred Sprague-Dawley rats were obtained from 
Charles River Laboratories, Wilmington, MA. The fetuses 
were removed at 15 days gestation under sterile conditions. 
The fetal lungs were dissected in ice-cold phosphate- 
buffered saline using a dissecting microscope. 
2.2. Organ culture 
The intact lung tissue was cultured at the gas-liquid 
interface on Millipore filter paper (GS 0.22 um) supported 
by stainless steel grids in tissue culture dishes. The cul- 
tures were grown in 60 X 15 mm sterile plastic tissue 
culture dishes (Falcon) with 10 ml Waymouths' MB 752/1 
medium (Sigma) containing 2.5% carbon-stripped fetal 
calf serum (Sigma) and 100 U/ml  penicillin and 0.1 
/zg/ml gentamicin [7]. Dexamethasone and epidermal 
growth factor (EGF) (Sigma) diluted to the concentrations 
specified for the experiments were added to the culture 
medium as indicated in the text. The cultures were placed 
on a rocker platform set at 3 cycles per min and incubated 
at 37°C in a humidified atmosphere of 95% air and 5% 
CO 2. Cultures were harvested on the third and sixth days 
of culture. Medium was changed on the third day. The 
cultures were harvested by removing the lungs from the 
filter with a sterile blade. They were transferred to 
RNAse-free cryovials, immersed in liquid nitrogen, and 
stored at -70°C until processed. For most experiments, 
lungs from different litters were pooled and distributed 
among hormone-treated samples, controls, and the 15-day 
gestation sample which was analyzed along with the cul- 
tured tissues. Experiments were performed with two or 
three independent RNA preparations from different ani- 
mals. 
2.3. RNA preparation and analysis 
About 20 mg tissue from organ culture or fetal lung at 
15 days gestation was used for extraction of total RNA 
using guanidinium thiocyanate [8]. For Northern blot anal- 
ysis, 10 /zg of total RNA from different samples was 
separated on a 1% agarose gel with 6.6% formaldehyde 
and transferred overnight o nylon membrane (MSI, West- 
borough, MA). The membrane was baked for 1 h at 80°C. 
Northern blots were hybridized with a 600 bp rat kidney 
APN cDNA probe [9] in 50% formamide at 42°C overnight. 
The cDNA probe was labeled with [a32-p]dCTP, 3000 
Ci /mmol using the random oligonucleotide priming 
method of Feinberg and Vogelstein [10,11]. The filters 
were prehybridized for 2-3 h at 42°C in 5 X standard 
sodium phosphate EDTA (SSPE) (1 X SSPE is 0.15 M 
NaC1, 10 mM NaH2PO 4, 1 mM EDTA), 5 X Denhardt's 
solution, 150 /zg/ml salmon sperm DNA, 50% for- 
mamide, 0.2% SDS, 10% dextran sulfate. Hybridization 
was then conducted overnight at 42°C in a hybridization 
solution of 5 X SSPE, 2.5 X Denhardt's solution, 150 
/~g/ml salmon sperm DNA, 50% formamide, 0.2% SDS, 
and 10% dextran sulfate. Filters were washed in 5 × SSPE 
with 0.5% SDS for 30 min at 42°C, then for 30 min in 
1 X SSPE with 0.5% SDS at 42°C, and finally in 0.1 X 
SSPE with 1% SDS for 30 min at 65°C. Filters were then 
wrapped in plastic wrap and exposed to X-ray film (Kodak, 
X-OMAT AR) at -70°C. The Northern blots were also 
probed with a 460 bp rat SP-A cDNA probe kindly 
provided by Dr. S.L. Katyal (University of Pittsburg) and a 
1.8 kb chicken fl-actin cDNA probe (gift of Dr. Warren 
Zimmer and A. Kovacs, University of South Alabama). 
Some blots were also probed with a 4.8 kb insert from 28S 
ribosomal subunit in pBR322, also a gift of Warren Zim- 
mer, to estimate relative amounts of RNA in each lane. 
Protocols, including temperature and hybridization condi- 
tions, were the same as used for the APN cDNA hybridiza- 
tion experiments. Blots analyzed with more than one probe 
were stripped by boiling in 1 X SSC with 0.1% SDS for 15 
min. A scanning video densitometer (Biomed Insruments) 
was used to estimate relative amounts of mRNA from the 
Northern blots. For the densitometric analysis of the blots 
probed with the SP-A cDNA, data from the larger of the 
two SP-A bands were used. As noted by Nichols et al. 
[12], the data from the smaller band revealed similar 
changes during development. Two or more autoradio- 
graphic exposures were used for each blot to obtain signals 
in the linear range of the film response. RNA concentra- 
tion for loading gels for Northern analysis was estimated 
from Absorbance at 260 nm. 
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2.4. Light and electron microscopy 
For morphologic studies, tissues from 6 timed-bred 
animals were harvested and randomly divided into groups 
of 5 lungs each for EGF-and dexamethasone-treated nd 
control cultures. Four cultures from each group were fixed 
in Kamovsky's electron microscopy fixative [13] for 4 h at 
room temperature. After fixation tissues were washed with 
acetate buffer (pH 7.4), and postfixed in 1.5% OsO 4 
overnight at 4°C. After dehydration with a graded series of 
acetone solutions, the tissues were infiltrated with Spurr's 
embedding medium in acetone and embedded in Spurr's 
embedding medium. For light microscopy 1-/xm sections 
were stained with 0.5% alkaline Toluidine blue. Tissues 
were examined and representative s ctions were chosen for 
Table 1 
Increases in expression of APN mRNA in fetal rat lung during organ 
culture 
Percent expression relative to 
value at 15 days gestation 
APN Actin 
Cultured 3 days 278 ± 28 72 + 18 
Cultured 6 days 1025 5- 22 87 ± 14 
Northern blot analyses were performed on total RNA fractions from fetal 
rat lung at 15 days gestation (not cultured) and cultured for 3 and 6 days. 
cDNA probes are described in Section 2. Data were obtained from 
autoradiography and densitometry. Densities for APN were normalized to 
values for actin on the same blot, and those for actin were normalized to 
the 28S ribosomal subunit. Values are expressed relative to the value 
obtained from the 15 days gestation noncultured lung. The data are 
mean + S.E. from 3 or 4 determinations. 
Fig. 1. Light and transmission electron microscopy analyses of fetal lung after 6 days in organ culture. Fetal lung was dissected at 15 days gestational ge 
and processed for light and electron microscopy (panels A and B) or cultured for 6 days as described in Section 2 prior to processing for microscopy 
(panels C and D). Panels A and C are from 1 /xm plastic sections (bar = 35 /xm). Electron micrographs are shown as panels B and D (bar = 2.6 ~m). The 
developing alveolar lumen is indicated by L and glycogen deposits by G. 
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Table 2 
Summary of data from densitometry of autoradiographs from Northern blots prepared and analyzed as described for Fig. 
195 
Percent expression relative to controls 
10 nM Dex 100 nM Dex 10 ng/ml EGF 20 ng/ml EGF 
Three-day cultures 
APN 235 + 20 b 309 + 56 c 285 + 58 c 297 + 30 b 
SP-A 437 + 33 a 388 ___ 15 a 97 + 5 98 4- 16 
Six-day cultures 
APN 107 + 14 99 + 17 185 4- 29 232 4- 46 
SP-A 191 4- [5 b 1354-9 c 115-1-5 c 1264-24 
The values represent means with S.E. of three Northern analyses from two separate xperiments. The densities were 
/3-actin. Values obtained in the presence of dexamethasone or EGF are expressed relative to controls cultured for the 
additions. 
a p < 0.005, b p < 0.025, c p < I).050 versus control, n = 3. 
normalized to values obtained for 
same length of time without hese 
photography. For electron microscopy, 70-nm sections from 
the same specimens used for light microscopy were stained 
with uranyl acetate (2%) and lead citrate (1%) for 10 min. 
Representative fi lds were chosen for photography. 
2.5. Statistical analysis 
Data shown in Table 2 were analyzed by means of a 
one-tailed Student's t-test. Since values were compared to 
control values set as one, t=(mean va lue-1) -S .E . ;  
d.f. = 2. 
3. Results 
Expression of APN ml~qA in fetal lung in organ cul- 
ture 
When placed in organ culture at 15 days gestational 
age, the fetal rat lung is z. glandular organ with a primor- 
dial tubular system lined by undifferentiated columnar 
epithelial cells [14]. During the 6-day organ culture in 
medium supplemented with 2.5% carbon-stripped fetal calf 
serum, the morphology changed to include alveolar-like 
tubules lined by cuboidal epithelial cells containing lamel- 
lar bodies (Fig. 1). At the., same time, APN mRNA levels 
in total RNA increased approximately 10-fold. The /3-actin 
mRNA levels remained unchanged, indicating that the total 
mRNA levels in RNA did not increase during the develop- 
ment in culture. These data are summarized in Table 1. 
Comparison of the in vitro organ culture studies with 
previously published studies of expression of APN during 
in utero lung development revealed a similar time course. 
For example, an 8-fold increase in relative APN mRNA 
levels was observed between gestational days 16 and 22 in 
the in utero studies [6]. Surfactant-associated protein A 
(SP-A) mRNA levels were also examined in the culture 
system, since SP-A is a well-characterized marker for lung 
development. SP-A is expressed by alveolar type II cells 
and nonciliated bronchial epithelial (Clara) cells [15,16]. 
The SP-A mRNA increased as expected if epithelial cell 
differentiation occurred uring the 6 days culture. SP-A 
mRNA was variably detectable at the 15th day of gesta- 
tion, was consistently detected at 3 days in culture, and 
became prominent at the 6th day in culture. This can be 
seen by examination of lanes representing fetal lung at 15 
days gestation and untreated controls in the representative 
Northern analysis presented in Fig. 2, bottom panel. 
Schellhase t al. reported the ontogeny of SP-A mRNA 
in developing rat lung in utero as assayed by Northem 
analysis [17]. The SP-A mRNA was first detectable at 
gestation day 18 and increased through day 21 to levels 
below those observed in adult lung. Since the third day of 
culture corresponds temporally to the 18th gestation day, 
the SP-A expression i organ culture reflects a time course 
similar to that observed in utero. Published in vitro studies 
of expression of SP-A mRNA in rat fetal lung explants do 
not include gestation stages prior to day 18, and they were 
conducted with diced lung tissue because of the size of the 
lung at day 18 [12]. Therefore, the results are not directly 
comparable tothose reported here. Interestingly the prema- 
ture induction of expression of markers of differentiation 
observed when fetal tissue is cut into explants and cultured 
[18] does not occur in this system where the lung tissue is 
cultured intact. 
3.1. Effect of dexamethasone and EGF on expression of 
aminopeptidase N during fetal lung development 
The fetal rat lung at 15 days gestation was cultured for 
3 and 6 days in the presence of 10 nM and 100 nM 
Fig. 2. Northern blot analyses of total RNA fractions from fetal lung (15 days gestation) cultured for different intervals in the presence and absence of 
dexamethasone and EGF. Dexamethasone (10 and 100 nM) and EGF (10 and 20 ng/ml) were added to organ cultures of fetal lung. Lungs were harvested 
after 3 and 6 days in culture and total RNA extracted and analyzed as described in Section 2. For the Northern analyses, 10 /xg total RNA was separated in
each lane. The 32 P-labeled cDNA probes used were a 600 bp probe from the rat kidney APN, a 460 bp rat SP-A cDNA, and a 1.8-kb chicken beta-actin 
probe. Representative blots probed with APN and beta-actin cDNA (top panel) and SP-A and beta-actin cDNA (bottom panel) are shown. 
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Fig. 3. Light and transmission electron microscopy analyses of effects of EGF and dexamethasone on morphology of fetal lung after 3 days in culture. 
Photomicrographs of fetal rat lung dissected at 15 days gestation age and cultured for 3 days in media alone (A and B), media with 20 ng/ml  EGF (C and 
D) and media with 100 nM dexamethasone (E and F). A, C and E are from 1-/xm plastic sections; B, D and F are electron micrographs. Bar for A, C and 
E = 40 /zm and for B, D and F = 4.4/xm. Note alveolar lumen (L) and glycogen pools (G). Arrows on F point to lamellar bodies. 
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dexamethasone and 10 ng/ml and 20 ng/ml EGF. Dexa- 
methasone and EGF have been reported to accelerate 
development of fetal lung iLn vitro, based on studies of their 
effects on phospholipid and protein components of the 
pulmonary surfactant system in a number of species [19]. 
Fig. 2 shows Northern analyses from a representative 
experiment where total mRNA levels were determined in
uncultured 15-day gestation lung and in lung cultured with 
dexamethasone, EGF, and without these additions. APN, 
SP-A and fl-actin cDNA probes were used for the analy- 
ses, and experiments were performed with two indepen- 
dent RNA preparations with similar results. Results for 
APN expression are shown in the top panel of Fig. 2, and 
those for SP-A at the bottom. Table 2 summarizes densito- 
metric data from 3 separate Northern blots. The APN and 
SP-A data have been normalized using the /3-actin values 
and are expressed relative to the control value which 
represents lungs cultured simultaneously without he addi- 
tion of dexamethasone or EGF. 
As shown by data in Table 2, the presence of dexa- 
methasone or EGF in the,, culture medium resulted in an 
approximately 3-fold increase in the steady-state l vels of 
the APN mRNA in the fetal lung cultured for 3 days 
compared to controls cul~:ured without dexamethasone or 
EGF. Dexamethasone at 10 and 100 nM increased SP-A 
levels approximately 4-fold. No effect of EGF on SP-A 
mRNA levels was observed. Morphological analysis of the 
hormone-treated and control cultures indicated both hor- 
mones had produced significant changes in alveolar epithe- 
lial cell morphology and ~lveolar development by the third 
day in culture. At the light microscope l vel, it is apparent 
that dexamethasone produced a profound decrease in the 
thickness of the alveolar ~,~eptal regions and an increase in 
the size of the alveolar-like spaces (Fig. 3, compare panels 
A and E). EGF also increased the size of the alveolar-like 
spaces, but considerably ess thinning of the septal regions 
was observed than in the dexamethasone-treated cultures. 
At the electron microscope level, the epithelial cells 
cultured with dexamethasone had a distinctly more cuboidal 
shape than controls (Fig. 3, compare panels B and F), 
indicating an effect on the transition of the undifferentiated 
columnar epithelial cells to a more cuboidal, differentiated 
cell morphology. Cells in cultures treated with EGF also 
had a more cuboidal shape, but the effect seemed less 
pronounced than in the dexamethasone-treated cultures. 
The alveolar type II cells in dexamethasone-treated cul- 
tures had distinct lamellar bodies, sometimes appearing in 
clusters (Fig. 3, panel F). These organelles, which repre- 
sent intracellular surfactant, were rarely seen in the EGF- 
treated cultures and were not seen in the untreated cultures. 
Both dexamethasone and EGF increased accumulation of 
glycogen in the alveolar cells, dexamethasone more than 
EGF. Generally an inver~;e temporal relationship between 
glycogen and phospholipid content is observed in lung 
alveolar epithelial cells during development [20-22]; how- 
ever, glycogen is not totztlly depleted in rat lung until the 
postnatal period [23]. Earlier studies of glycogen accumu- 
lation in fetal rat lung in organ culture demonstrated 
accumulation of glycogen during the first 6 days in culture 
and depletion during days 7 to 12 in culture [7]. 
Comparison of the data from Northern analysis after 3 
days in culture (Table 2) with the epithelial cell morphol- 
ogy suggests that the steady-state levels of APN transcript 
are similar in the epithelial cells treated with EGF which 
appear to be in transition to mature cuboidal cells (Fig. 3, 
panel D) and in epithelial cells treated with dexamethasone 
which already have the pronounced cuboidal shape, mi- 
crovilli, and prominent lamellar bodies characteristic of 
alveolar type II cells (Fig. 3, panel F). Dexamethasone did 
not increase the levels of APN mRNA above controls at 
the 6th day of culture, and had little effect on SP-A mRNA 
levels. The effects of EGF on APN mRNA levels at the 
6th day in culture were less than in 3-day cultures. As in 
the 3-day cultures, EGF had little or no effect on SP-A 
mRNA levels. 
From the data shown in Table 1, the APN transcript 
levels at 6 days culture are about 3.5 times those at 3 days 
culture. At the third day of culture, the dexamethasone-or 
EGF-treated cultures had levels of APN transcript approxi- 
mately 3-fold greater than the control cultures. Thus APN 
transcript levels in hormone-treated cultures at 3 days in 
culture are similar to the control cultures at 6 days in 
culture. The morphological differentiation f epithelial cells 
is also similar in dexamethasone-treated 3-day cultures and 
in untreated 6-day cultures. Compare Fig. 1, panels C and 
D, with Fig. 3, panels E and F. This is consistent with a 
hormone-accelerated transition of the epithelium to a more 
mature form expressing the maximum levels of APN 
transcript after 3 days in culture. The hormones appear to 
have little or no effect on APN or SP-A transcript levels in 
the relatively mature alveolar cells. 
4. Discussion 
The results demonstrate hat the fetal rat lung in organ 
culture up-regulates the steady-state levels of APN mRNA 
similar to the developmental changes observed uring fetal 
lung development in utero, where APN mRNA and im- 
munoreactive APN protein levels have been shown to 
increase 8-to 10-fold between gestation days 16 and 22 [6]. 
The effects of dexamethasone and EGF on APN expres- 
sion and morphology are consistent with an acceleration of
lung development resulting in the increased APN expres- 
sion, perhaps as a result of type II cell differentiation. 
The use of the organ culture system demonstrates that 
the glucocorticoid and EGF are affecting APN expression 
by directly influencing the lung; however, the results do 
not establish that the primary target is the type II cell since 
the entire fetal lung is cultured. The effects of glucocorti- 
coids on lung development and particularly on the pul- 
monary surfactant system of the type II cells have been 
198 S.D. Tangada et al. / Biochimica et Biophysica Acta 1268 (1995) 191-199 
studied for many years without a complete understanding 
of the mechanisms involved [19,24,25]. In addition to the 
type II cell, the lung fibroblast has received attention as a 
potential lung target cell mediating lucocorticoid effects 
on the pulmonary surfactant system by producing a soluble 
differentiation factor. Smith et al. described a glucocorti- 
coid-inducible fibroblast pneumonocyte factor produced by 
lung fibroblasts which stimulates urfactant phospholipid 
synthesis by alveolar type II cells [26]. See Ref. [24] for 
additional references. However, the factor has not yet been 
purified and characterized, and its role in lung develop- 
ment is not yet established. At the molecular level, it is 
known that the flanking regions of the SP-A and SP-B 
genes have consensus sequences for binding of glucocorti- 
coid receptors [19]. These findings are consistent with a 
direct involvment of glucocorticoid response lements in 
regulation of these surfactant-associated protein genes, but 
the involvment of glucocorticoid response lements has 
not been established. 
Glucocorticoid effects on APN expression have not 
been extensively investigated in extrapulmonary tissues 
where APN is expressed. However, dexamethasone has 
been reported to exert effects on the appearance of brush 
border enzyme activities, including APN, during differenti- 
ation of the intestine in organ culture [27,28]. There is 
evidence that the effect of dexamethasone on expression of 
brush border enzymes is at the transcriptional level [27]. 
However, the regulation of the APN gene is just beginning 
to be explored. Characterization f the 5'-flanking region 
indicates that in the human two different promoters epa- 
rated by an 8 kb intron are involved in expression of the 
single APN gene [5]. Consensus equences for glucocorti- 
coid receptor binding have not yet been identified in the 
available flanking regions, and introns are not yet charac- 
terized. 
It is not unexpected that EGF increases the steady-state 
levels of APN during fetal lung development since EGF 
has been shown to have effects on epithelial cell prolifera- 
tion and differentiation i a number of different issues 
[29], including the lung. The effects of EGF on fetal lung 
development and alveolar type II cell differentiation are 
summarized in recent reviews [19,24,25]. These effects 
have been reported in several species using in vivo and in 
vitro techniques. Control of specific gene expression in 
developing lung tissue by EGF has been demonstrated 
only for SP-A, the most abundant of the surfactant-associ- 
ated proteins [30]. The lack of a significant effect on 
steady-state levels of SP-A mRNA in the cultured rat lung 
was unexpected in view of the significant effects of EGF 
on SP-A in human explant cultures [30] and effects on 
fetal rhesus monkey SP-A levels in vivo [31]. The reason 
for the discrepancy is not known, but could be related to 
species differences in regulatory mechanisms or perhaps a
dependence of the effect on gestational age. Species and 
developmental-stage related differences in SP-A response 
to glucocorticoids are well known [19]. 
In summary, we have shown that glucocorticoids and 
EGF, factors that have well-charcterized ffects on lung 
development and alveolar type II cell differentiation i a 
number of different species, increase the steady-state levels 
of APN mRNA in fetal rat lung during development in
organ culture. The EGF and glucocorticoid stimulation of 
APN expression is consistent with a general role for these 
factors in accelerating differentiation of type II cells since 
these are the cells that express APN in mature lung. The 
function of the APN in the alveolar epithelial cells is not 
known; however, it is known that in fetal lung the expres- 
sion of APN is upregulated atthe time of birth [6]. Recent 
studies with human fetal lung indicate that another CD 
antigen ectopeptidase, CD10/neutral endopeptidase 24.11 
(CD/NEP) may be involved in the mechanism for control- 
ling cell growth in lung by its role in catabolism of 
essential paracrine or autocrine growth factors [32]. One 
candidate for such a factor is gastrin-releasing peptide, a 
mammalian homologue of the amphibian peptide bombesin, 
produced by pulmonary neuroendocrine cells [33]. 
Bombesin has been shown to increase fetal lung growth 
and maturation; and, at least in mice, the gastrin-releasing 
peptide mRNA levels are increased just before birth [34]. 
We suggest hat APN may be one of several ectopepti- 
dases that participate in regulating lung growth and cell 
differentiation by mechanisms similar to that proposed for 
CD10/NEP. The characterization f APN expression in 
lung organ cultures indicates that the system will be useful 
for exploring this or other possibilities for APN function. 
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